-
-
Click here to edit your abstract
Abstract Submission is now closed
Important dates
Opening of Abstract submission: December 5, 2011
Deadline for abstract submission: January 15, 2012
Acknowledgement of acceptance/rejection of abstract: March 1st, 2012
The scientific program is constructed based on the submitted abstracts selected blindly by the Scientific Committee.
All presentations will be 3 or 5 minutes, each with 5 minutes discussion.
Information on how to prepare Abstracts, Difficult Cases and Videos
Type (or cut-and-paste) a short ASCII summary for your submission. It should not include the author/title information, which is entered separately.
Text must be in English and is limited to 300 words. Use generic names with manufacturer names, whenever possible. Tables will not be accepted in the abstract.
You will have to specify the field of your abstract within the following categories:
Dermatology
(Interventional) Radiology
Surgery
Other clinical field
Basic science
In addition to clinical and basic science abstracts, you can submit:
- Difficult case. You will need to submit the abstract, as well as the Power Point presentation as a PDF-file (clinical pictures, radiological data,…), at the same time, via the abstract submission web-site. This will enable the Scientific Committee to judge the interest of the presentation.
- Video on techniques. You will need to submit the abstract, as well as the Video presentation as a MP4-file, at the same time, via the abstract submission web-site. This will enable the Scientific Committee to judge the interest of the presentation.
- Poster sessions: 2 X 90 minute sessions will be allocated to reinforce their importance.
Poster size: 120cm X 90cm (Height: 120 cm X Width 90cm)
Regarding abbreviations for vascular anomalies, it is essential all ISSVA members speak the same language. Therefore, only those acknowledged by the ISSVA classification are accepted. They are the following:
IH: Infantile Hemangioma
RICH: Rapidly Involuting Congenital Hemangioma
NICH: Non Involuting Congenital Hemangioma
KMP: Kasabach-Merritt Phenomenon
KHE: Kaposiform Hemangioendothelioma
CM: Capillary Malformation
VM: Venous Malformation
BRBN: Blue Rubber Bleb Naevus Syndrome
GVM: Glomuvenous Malformation
LM: Lymphatic Malformation
AVM: ArterioVenous Malformation
CVM: CapillaroVenous Malformation AND NOT Congenital Vascular Malformation
KT: Klippel-Trenaunay syndrome
HHT: Hereditary Hemorrhagic Telangiectasia
CCM: Cerebral Cavernous Malformation
Abstract not following these guidelines will not be considered for Oral presentations!
Click here for submission page